Literature DB >> 11923233

BIGH3 mutation spectrum in corneal dystrophies.

Francis L Munier1, Beatrice E Frueh, Philippe Othenin-Girard, Sylvie Uffer, Pascal Cousin, Ming X Wang, Elise Héon, Graeme C M Black, Maria A Blasi, Emilio Balestrazzi, Birgit Lorenz, Rafael Escoto, Rafael Barraquer, Maria Hoeltzenbein, Balder Gloor, Maurizio Fossarello, Arun D Singh, Yvan Arsenijevic, Léonidas Zografos, Daniel F Schorderet.   

Abstract

PURPOSE: To investigate the molecular pathology underlying BIGH3-related corneal dystrophies (CDs) and to further delineate genotype-phenotype specificity.
METHODS: Sixty-one index patients with CDs were subjected to phenotypic and genotypic characterization. The corneal phenotypes of all patients were assessed by biomicroscopy and documented by slit lamp photography. The BIGH3 gene was amplified exon by exon from constitutional DNA to perform single-strand conformation polymorphism (SSCP) analysis, followed by direct bidirectional sequencing of abnormal conformers.
RESULTS: The phenotypes of CDs were classified as lattice CD in 30 patients, Groenouw type I in 12 (CDGGI), Avellino in 7 (CDA), Reis-Bückler in 8 (CDRB), and Thiel-Behnke in 4 (CDTB). Fifty occurrences of 16 distinct mutations were identified, including 8 novel mutations responsible for lattice type IIIA in three patients (CDLIIA), intermediate type I/IIIA (CDLI/IIIA) in four patients, and atypical CDL with deep deposits in one patient (CDL-deep).
CONCLUSIONS: Disease-causing mutations were identified in 80% of the patients (50/61). All mutations localize in two regions of kerato-epithelin: the amino acid R124 and BIGH3 fasc domain 4. This study also confirms the mutation hot spot at positions R124 and R555 with nearly 50% of the mutations targeting these two amino acids (24/50). In addition the corneal phenotypes induced by changes at R124 and R555 are amino acid specific: R124C in CDLI, R555W and R124S in CDGGI, R124H in CDA, R124L in CRRB, and R555Q in CDTB. In CDLIIIA, CDLI/IIIA, and CDL-deep the genotype-phenotype correlation is domain specific, with all changes occurring at the boundary or within the fasc4 domain.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11923233

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  73 in total

1.  TGFBI and CHST6 gene analysis in Chinese stromal corneal dystrophies.

Authors:  Yin Li; Tuo Li; Xiu-Sheng Song; Jia-Zhang Li; Qing-Song Wu; Hong-Yan Li
Journal:  Int J Ophthalmol       Date:  2012-06-18       Impact factor: 1.779

2.  Chinese family with atypical granular corneal dystrophy type I caused by the typical R555W mutation in TGFBI.

Authors:  Su-Juan Zhao; Ya-Nan Zhu; Xing-Chao Shentu; Qi Miao
Journal:  Int J Ophthalmol       Date:  2013-08-18       Impact factor: 1.779

3.  Homozygous mutation (L527R) of TGFBI in an individual with lattice corneal dystrophy.

Authors:  N Yamada; T-I Chikama; N Morishige; R Yanai; T Nishida; M Inui; K Seki
Journal:  Br J Ophthalmol       Date:  2005-06       Impact factor: 4.638

Review 4.  Amyloid-a state in many guises: survival of the fittest fibril fold.

Authors:  Jesper S Pedersen; Daniel E Otzen
Journal:  Protein Sci       Date:  2007-11-27       Impact factor: 6.725

5.  Crystallization and preliminary crystallographic analysis of the fourth FAS1 domain of human BigH3.

Authors:  Ji-Ho Yoo; EungKweon Kim; Jongsun Kim; Hyun-Soo Cho
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2007-09-29

6.  De novo mutation in the BIGH3/TGFB1 gene causing granular corneal dystrophy.

Authors:  E N Hilton; G C M Black; F D C Manson; D F Schorderet; F L Munier
Journal:  Br J Ophthalmol       Date:  2007-08       Impact factor: 4.638

7.  Mutation in transforming growth factor beta induced protein associated with granular corneal dystrophy type 1 reduces the proteolytic susceptibility through local structural stabilization.

Authors:  Jarl Underhaug; Heidi Koldsø; Kasper Runager; Jakob Toudahl Nielsen; Charlotte S Sørensen; Torsten Kristensen; Daniel E Otzen; Henrik Karring; Anders Malmendal; Birgit Schiøtt; Jan J Enghild; Niels Chr Nielsen
Journal:  Biochim Biophys Acta       Date:  2013-10-12

8.  Transforming growth factor β induced mutation-associated phenotype in a Chinese family exhibiting lattice corneal dystrophy.

Authors:  Chao Qu; Man Yu; Xiaoxin Guo; Jing Li; Xiaoqi Liu; Yi Shi; Bo Gong
Journal:  Biomed Rep       Date:  2017-08-30

9.  Novel mutations of CHST6 in Iranian patients with macular corneal dystrophy.

Authors:  Shiva Akbari Birgani; Zivar Salehi; Masoud Houshmand; Mohamad Javad Mohamadi; Leila Azizade Promehr; Zahra Mozafarzadeh
Journal:  Mol Vis       Date:  2009-02-18       Impact factor: 2.367

10.  A novel mutation I522N within the TGFBI gene caused lattice corneal dystrophy I.

Authors:  Chunmei Zhang; Guang Zeng; Hui Lin; Dandan Li; Liming Zhao; Nan Zhou; Yanhua Qi
Journal:  Mol Vis       Date:  2009-11-28       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.